The Medicare Payment Advisory Commission (MedPAC) convened a session to examine emerging challenges in the Medicare Part D program and potential policy directions for addressing recent spending growth. Staff emphasized that Part D continues to perform well on several measures, including high enrollment and beneficiary satisfaction, broad plan choice, and high generic utilization. At the same time, the Inflation Reduction… (Colocho, September 3, 2026) #Biosimilars, #Medicare Part D, #Prescription Drugs